Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation

OBJECTIVES: Costs may play a role in deciding how and when to start highly active antiretroviral therapy (HAART) in a naïve patient. The aim of the present study was to assess the cost- effectiveness of treatment with HAART in a large clinical cohort of naïve adults to determine the potential role o...

Descripción completa

Detalles Bibliográficos
Autores principales: Maggiolo, Franco, Colombo, Giorgio L, Di Matteo, Sergio, Bruno, Giacomo M, Astuti, Noemi, Di Filippo, Elisa, Masini, Giulia, Bernardini, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337626/
https://www.ncbi.nlm.nih.gov/pubmed/25733942
http://dx.doi.org/10.2147/PROM.S63586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337626/
https://www.ncbi.nlm.nih.gov/pubmed/25733942
http://dx.doi.org/10.2147/PROM.S63586

Ejemplares similares